Elanco Animal Health (STU:5EA) ROCE % : 19.95% (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Elanco Animal Health ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Elanco Animal Health's annualized ROCE % for the quarter that ended in Sep. 2024 was 19.95%.

Elanco Animal Health ROCE % Historical Data

The historical data trend for Elanco Animal Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elanco Animal Health ROCE % Chart

Elanco Animal Health Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

1.97

-4.29

-2.28

1.22

-6.72

Elanco Animal Health Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															-29.96	-1.81	2.41	1.05	19.95

Elanco Animal Health ROCE % Calculation

Elanco Animal Health's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-841.806	/	( ( (14623.504 - 1606.688)	+	(13169.954 - 1137.997) )	/ 2 )
	=	-841.806	/	( (13016.816	+	12031.957)	/ 2 )
	=	-841.806	/	12524.3865
	=	-6.72 %

Elanco Animal Health's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	2223.668	/	( ( (12786.756 - 1272.73)	+	(11967.983 - 1190.221) )	/ 2 )
	=	2223.668	/	( ( 11514.026	+	10777.762 )	/ 2 )
	=	2223.668	/	11145.894
	=	19.95 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Elanco Animal Health (STU:5EA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Elanco Animal Health ROCE % Related Terms

Thank you for viewing the detailed overview of Elanco Animal Health's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Elanco Animal Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elanco Animal Health Inc (STU:5EA) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

ELAN:USA

Address

2500 Innovation Way, Greenfield, IN, USA, 46140

Website

https://www.elanco.com

Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.

Elanco Animal Health Headlines

No Headlines